// App-Quantinova.ai

P1668 : SYNERGY OF RED BLOOD CELLS AND TRANEXAMIC ACID IN THE INHIBITION OF FIBRINOLYSIS

Researchers

Presenter

  • Alexandra Raska

Principal Investigators

  • Ian Roberts

  • Nikolett Wohner

Medical Centers

  • Department of Medical Biochemistry, Semmelweis University, Budapest, Hungary

  • Tropical Medicine,London,Royaume-uni

  • Tropical Medicine,London,Vereinigtes Königreich

  • Department of Medical Biochemistry, Semmelweis University, Budapest, Hungary

  • Department of Rheumatology and Internal Medicine

  • Clinical Trials Unit,London School of Hygiene &amp

  • Department of Hematology and Internal Medicine,Semmelweis University,Budapest,Hongrie

  • 2nd Department of Pediatrics,Semmelweis University,Budapest,

  • Tropical Medicine,London,Regno Unito

  • Department of Hematology and Internal Medicine,Semmelweis University,Budapest,Hongrie

  • Department of Medical Biochemistry, Semmelweis University, Budapest, Hungary

  • Department of Medical Biochemistry, Semmelweis University, Budapest, Hungary

  • Department of Medical Biochemistry, Semmelweis University, Budapest, Hungary

  • Department of Hematology and Internal Medicine,Semmelweis University,Budapest,Hongrie

  • Clinical Trial

  • De

  • Department of Hematology and Internal Medicine,Semmelweis University,Budapest,Hongrie

  • Tropical Medicine, London, United Kingdom

Locations

  • Hungary

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Tranexamic acid

  • Caprilon

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved